F

Fraser Mcleod

About

Detail

Growth Executive | Global R&D, Product Management, Sales Management & Commercialization
Concord, Massachusetts, United States

Contact Fraser regarding: 
work
Full-time jobs

Timeline


work
Job
school
Education

Résumé


Jobs verified_user 0% verified
  • NanoImaging Services
    Chief Executive Officer
    NanoImaging Services
    Mar 2026 - Current (8 months)
  • Biosero
    Managing Director
    Biosero
    Sep 2025 - Mar 2026 (7 months)
    Lead the Biosero business with a focus on delivering high quality automation solutions in pharma / biopharma / biotech
  • Ampersand Capital Partners
    Executive in Residence
    Ampersand Capital Partners
    Jun 2025 - Sep 2025 (4 months)
  • Waters Corporation
    VP/GM, QA/QC and Wyatt Technology
    Waters Corporation
    May 2023 - May 2025 (2 years 1 month)
    Heading up a new organization with a focus on serving customers in QA/QC and portfolio responsibility for HPLC, UPLC, SFC, Empower, and NuGenesis. Also heading up the Wyatt Technology business, a recent acquisition for Waters Corporation
  • Waters Corporation
    VP/GM, QA/QC
    Waters Corporation
    Jun 2022 - May 2023 (1 year)
    Heading up a new organization with a focus on serving customers in QA/QC and portfolio responsibility for HPLC, UPLC, SFC, Empower, and NuGenesis
  • Danaher Corporation
    VP, Life Sciences Digital
    Danaher Corporation
    Nov 2021 - Jun 2022 (8 months)
    Lead the digital strategy for the Danaher Life Sciences business platform and a digital organization focused on using data and analytics to help biopharma customers innovate faster and execute more efficiently
  • Danaher Corporation
    VP, Digital and Informatics Strategy
    Danaher Corporation
    Apr 2020 - Nov 2021 (1 year 8 months)
    Drive the digital transformation and informatics strategy for the Danaher Life Sciences group. Danaher is a science and technology innovator committed to our Shared Purpose of Helping Realize Life's Potential. We are a diverse team of people and operating companies, each with unique missions and challenges. Yet, we are united by our Shared Purpose, which directs how we live out every day to achieve our most ambitious goals. Our Shared Purpose confirms our commitment to helping our customers achieve amazing things and the high standards by which we measure our own success. We innovate forward-looking technologies to solve our customers’ most complex challenges. We are their agents of possibility. Our Shared Purpose has its foundation in our
  • SCIEX
    Vice President & General Manager, Software Business
    SCIEX
    May 2017 - Apr 2020 (3 years)
    SCIEX is a $1B global leader in mass spectrometry. SCIEX joined the $18B Danaher portfolio in 2010 and has gained share through its cutting-edge product development. Joined Sciex as Vice President and General Manager to create and lead new business unit focused on increasing software revenues through commercial activities, strategic planning, and talent acquisition. With full P&L accountability, enhances margins, finds short-term revenue for long-term goals, and eradicates waste found within discovery. Talent magnet and talent exporter that simultaneously leads sales, product, market research, development and technical teams. Picks the right M&A candidates and merges assets across IP, data and strategy to form new products and net new reven
  • Thermo Fisher Scientific
    Vice President Protein Purification and Chromatography Business Development
    Thermo Fisher Scientific
    Jul 2015 - Apr 2017 (1 year 10 months)
    The main activities are - Leading a cross-divisional marketing team focused on demonstrating breadth of capabilities in protein purification and analytics - Developing a business strategy around opportunities in protein purification
  • Thermo Fisher Scientific
    Vice President & General Manager, HPLC
    Thermo Fisher Scientific
    Jan 2013 - Jun 2015 (2 years 6 months)
    I lead a team responsible for R&D for HPLC systems Manufacturing of HPLC systems Marketing of HPLC systems and solutions HR Finance Administration
  • Thermo Fisher Scientific
    Vice President, Chromatography Software
    Thermo Fisher Scientific
    Feb 2012 - Jan 2013 (1 year)
    Leading a team that develops and markets chromatography software
  • Thermo Fisher Scientific
    Senior Director, HPLC Product and Solutions Marketing
    Thermo Fisher Scientific
    Oct 2007 - Feb 2012 (4 years 5 months)
    I am responsible for a cross-functional team of 34 people, and the product portfolio for the HPLC Product Line (LSBU) of Thermo Fisher Scientific. This includes the UltiMate 3000 HPLC product line, the Chromeleon Chromatography Data System, DCMSLink, and all HPLC application solutions.
  • Thermo Fisher Scientific
    Director
    Thermo Fisher Scientific
    Jan 2007 - Feb 2012 (5 years 2 months)
    Managed the strategic development and execution of product marketing campaigns for HPLC software and instrumentation. Staff size managed: 34 (includes remote staff in US, UK, and the Netherlands) Created the UHPLC+ campaign and strategy for the UltiMate 3000 instrumentation. This transformed the product line into an industry leading one and resulted in high double digit organic growth. Managed multiple product launches in a short time. This includes the UltiMate 3000 RSLC system, the RSLCnano system, multiple Chromeleon updates, new Corona Charged Aerosol Detectors, and Viper/nanoViper. All products launched have high double-digit growth Core team member of the integration of the legacy Dionex HPLC business into Thermo Fisher Scientific. De
  • D
    Product Manager Chromatography Software
    Dionex
    Oct 2004 - Oct 2007 (3 years 1 month)
  • D
    Product Manager
    Dionex
    Jan 2004 - Jan 2007 (3 years 1 month)
    Chromatography Software 2004 to 2007 Managed the strategic development and execution of product marketing campaigns for HPLC software Staff size managed: 4 Designed the feature specification and overall user interface concept for Chromeleon 7. Includes 2 pending patents Launched the DCMSLink product, which provided control of Dionex HPLCs from the software of partner MS companies. Invented and introduced the Chromeleon Extension pack; an add-on for Chromeleon that automated many of the calculation and reporting steps for pharmaceutical methods, providing time savings of up to 95%
  • D
    Field Specialist
    Dionex
    Oct 2001 - Oct 2004 (3 years 1 month)
  • D
    Field Operative
    Dionex
    Jan 2001 - Jan 2004 (3 years 1 month)
    Responsible for sales and service support for large scale installations of Chromeleon in Europe Integral part of the team that won the Novartis contract for Chromeleon. This is now an installation of over 3,000 seats. Project management for various other large scale installations e.g
  • IQVIA
    Manager Laboratory Data Systems
    IQVIA
    Sep 1999 - Sep 2001 (2 years 1 month)
  • IQVIA
    Team Leader/SW Manager
    IQVIA
    Jan 1997 - Jan 2001 (4 years 1 month)
    Managed a team of 8 analysts in the Pharmaceutical Analysis department. Also responsible for all software deployed in the department, including Chromeleon. Dealt with over 30 projects for 10 different pharmaceutical companies. Had a track record for highest efficiency with client projects and typically had to handle the most challenging projects Assessed all SW packages for compliance with 21 CFR Part 11 and coordinated any improvements required with vendors. Gave several presentations at scientific conferences on best practice for complying with 21 CFR Part 11. Introduce automated routines for HPLC and GC in Chromeleon, increasing productivity in the department by 30%
  • S
    Team Leader/SW Manager
    Scotia Pharmaceuticals
    Jan 1993 - Jan 1997 (4 years 1 month)
Education verified_user 0% verified
  • University of Strathclyde
    Post Graduate Diploma, Analytical and Process Analytical Chemistry
    University of Strathclyde
    Jan 1988 - Jan 1991 (3 years 1 month)
  • University of Strathclyde
    B. Sc, Chemistry
    University of Strathclyde
    Jan 1988 - Jan 1991 (3 years 1 month)
This is a community-created genome.